Disease / Causative Organisms

Mode of Transmission

Type of Precautions

Duration of Precautions

*ANTHRAX
(Bacillus anthracis)
• Not transmitted from person-to-person ROUTINE At all times
*BOTULISM
(Clostridium botulinum)
• Not transmitted from person-to-person ROUTINE At all times
COXSACKIEVIRUS
(Enteroviral infection)
• Droplet
• Direct Contact
ROUTINE: Adult At all times
CONTACT: Pediatric Duration of illness
*CREUTZFELDT- JAKOB DISEASE (CJD)
(Subacute spongiform encephalopathy)
• Direct and indirect contact ROUTINE At all times

Contact Infection Control for additional information

*CYTOMEGALOVIRUS (CMV) • Direct contact
• Mucosal exposure to infective body fluids
ROUTINE At all times
*ENCEPHALITIS • Direct and indirect contact
• Fecal / oral route
ROUTINE: Adult Until specific etiology established or enterovirus ruled out
CONTACT: Pediatric
ENTEROBIASIS
(Enterobius vermicularis,
oxyuriasis, pinworm)
• Direct Contact ROUTINE At all times
EPIGLOTTITIS
(*Haemophilus influenzae
type b, *Group A
streptococcus (iGas) invasive,
Staphylococcus aureus)
• Droplet
• Direct Contact
ROUTINE: Adult At all times
DROPLET: Pediatric if Haemophilus influenzae type b, otherwise Routine Until 24 hours of effective antimicrobial therapy received unless Haemophilus influenzae type b ruled out
EPSTEIN-BARR VIRUS
(Infectious mononucleosi
• Direct and indirect contact ROUTINE At all times
ERYTHEMA
INFECTIOSUM
( Parvovirus B-19, Fifth disease)
• Droplet
• Direct Contact
ROUTINE: Fifth Disease At all times
DROPLET: Aplastic Crisis 7 days for patients with transient Aplastic or Erythrocyte crisis
For duration of hospitalization
for immunocompromised patients with chronic infection
HAND, FOOT and
MOUTH DISEASE
• Direct and indirect contact
• Fecal / oral route
ROUTINE: Adult At all times
CONTACT: Pediatric Duration of illness
*HAEMOPHILUS INFLUENZAE TYPE B
(invasive disease)
• Droplet
• Direct Contact
ROUTINE: Adult At all times
DROPLET: Pediatric Until 24 hours after effective antibiotic therapy
*HEMORRHAGIC FEVER
(*Ebola, *Lassa Fever,
*Marburg Virus, *other viral causes)
• Direct and indirect contact
• Possibly airborne if pneumonia

CONTACT & DROPLET
or
CONTACT & AIRBORNE if pneumonia

Until symptoms resolve

For Lassa Fever - duration
of viral shedding

*HEPATITIS B, C, D • Mucosal or percutaneous exposure to infective body fluids ROUTINE At all times
*HERPES SIMPLEX
VIRUS (HSV)
• Direct Contact Encephalitis: ROUTINE At all times
Mucocutaneous: (disseminated or primary & extensive): CONTACT
 
*Neonatal: CONTACT
 
Recurrent: Routine

Until lesions resolved

Duration of illness

At all times

HIV
(Human Immunodeficiency Virus)

*AIDS
(Acquired Immunodeficiency Syndrome)

• Mucosal or percutaneous exposure to infective body fluids
• Blood transfusion or organ transplant if contaminated blood or organ
• Infected mother to the fetus or baby
• Breast milk
ROUTINE

At all times

 *LEGIONNAIRES' DISEASE
(Legionella pneumophila)
 • Not transmitted from person-to-person  ROUTINE  At all times
LICE
(Pediculosis)
• Direct and indirect contact ROUTINE  At all times
CONTACT if in pediatric unit
or if heavily infected
Until 24 hours after effective treatment
*Lyme Disease
(Borrelia burgdorferi)
• Not transmitted from person-to-person ROUTINE

At all times

*MALARIA
(Plasmodium sp.)
• Not transmitted from person-to-person ROUTINE

At all times

RHEUMATIC FEVER • Not transmitted from person-to-person ROUTINE

At all times

ROSEOLA
(Roseola Infantum, Exanthem Subitum,
Human Herpesvirus 6, Sixth disease)
• Direct Contact ROUTINE

At all times

SCABIES
(Sarcoptes scabiei)
• Direct and indirect contact CONTACT Until 24 hours after
effective treatment
*WEST NILE VIRUS • Not transmitted from person-to-person ROUTINE

At all times

*YELLOW FEVER • Not transmitted from person-to-person ROUTINE

At all times